BioSpace News Archive

Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today announced the hiring of industry veteran Girish Aakalu, Ph.D., as its new Chief Business Officer. I

Advancing medical device safety remains a top priority of the U.S. Food and Drug Administration. This means we are committed to communicating when new, relevant information becomes available about device safety risks, to ensure doctors and patients are better informed about device benefits and risks.

Organogenesis Holdings Inc. today announced the completion of its previously announced business combination between Organogenesis Inc. and Avista Healthcare Public Acquisition Corp. (“AHPAC”).

Bryce Williams, president & CEO of HealthMine, Inc., the Health Action as a Service company (HAaaS), will be presenting at the 9th Annual RISE Star Ratings Master Class. Williams will present on “Improving star quality ratings: how to think like a start-up to drive clinical health action,” on Wednesday, December 12th from 11:00 AM - 11:25 AM at the Fairmont Grand Del Mar Hotel in San Diego, California.

Younger siblings of children with attention deficit hyperactivity disorder (ADHD) or autism spectrum disorder are more likely to develop either disorder, according to a new study.

Today, The Independence Fund announces a partnership with the Veterans Health Administration (VHA) Office of Mental Health and Suicide Prevention (OMHSP) to aggressively combat the issue of Veteran suicide in the United States.

A Pathologist Shares Her Own Breast Cancer Journey and the Promise of Precision Medicine

More than 100 drug discovery projects now supported by Harrington Discovery Institute

The Bob & Renee Parsons Foundation has issued a $500,000 matching grant to aid HonorHealth in its expansion of the heart and vascular services offered at the HonorHealth Shea Medical Center.

A new scholarship advancing addiction recovery in the state of Vermont has been established to support the Vermont Foundation of Recovery (VFOR) by Dominion Diagnostics, a leading national medical laboratory with a two-decade long history in the state and deep roots in its treatment and recovery community.